Compare Stocks

→ Biggest hedge fund manager has huge warning for U.S. dollar (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXR Daxor	$9.55 -1.2%	$9.02	$7.11 ▼ $13.13	$45.23M	-0.45	3,394 shs	299 shs
INVO INVO Bioscience	$1.01 +11.0%	$1.05	$0.50 ▼ $8.60	$2.77M	1.48	2.68 million shs	326,870 shs
MOTS Motus GI	$0.07	$0.35	$0.05 ▼ $23.40	$355K	1.5	1.21 million shs	16,588 shs
RDGL Vivos	$0.20 +22.9%	$0.10	$0.04 ▼ $0.24	$77.77M	1.05	1.08 million shs	2.45 million shs
SINT Sintx Technologies	$0.04	$0.07	$0.02 ▼ $1.82	$905K	1.39	23.23 million shs	20.06 million shs

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXR Daxor	-1.33%	-1.93%	-0.72%	+8.85%	+966,999,900.00%
INVO INVO Bioscience	-1.42%	-1.53%	+7.47%	-0.35%	-87.13%
MOTS Motus GI	-6.32%	-2.22%	-84.91%	-89.00%	-99.42%
RDGL Vivos	-3.10%	-21.73%	+100.39%	+187.63%	+126.11%
SINT Sintx Technologies	-1.58%	-7.22%	+71.37%	-70.17%	-96.97%

The Crypto 9-5 Escape Plan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INVO INVO Bioscience	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MOTS Motus GI	1.374 of 5 stars	3.5	3.0	0.0	0.0	1.1	0.0	0.6
RDGL Vivos	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DXR Daxor	N/A	N/A	N/A	N/A
INVO INVO Bioscience	N/A	N/A	N/A	N/A
MOTS Motus GI	3.00	Buy	$28.88	40,857.45% Upside
RDGL Vivos	N/A	N/A	N/A	N/A
SINT Sintx Technologies	2.00	Hold	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DXR Daxor	$1.28M	35.32	N/A	N/A	N/A	∞
INVO INVO Bioscience	$3.02M	0.92	N/A	N/A	($2.06) per share	-0.49
MOTS Motus GI	$319K	1.11	N/A	N/A	$1.74 per share	0.04
RDGL Vivos	$20K	3,888.70	N/A	N/A	($0.02) per share	-10.00
SINT Sintx Technologies	$1.23M	0.74	N/A	N/A	$1.65 per share	0.02

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DXR Daxor	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
INVO INVO Bioscience	-$8.03M	-$12.36	N/A	∞	N/A	-459.42%	N/A	-88.87%	5/20/2024 (Estimated)
MOTS Motus GI	-$12.87M	-$28.55	N/A	∞	N/A	-4,033.54%	N/A	-110.70%	N/A
RDGL Vivos	-$2.89M	N/A	0.00	∞	N/A	-9,524.89%	N/A	-180.12%	N/A
SINT Sintx Technologies	-$8.26M	-$3.42	N/A	∞	N/A	-314.39%	-67.12%	-45.49%	5/20/2024 (Estimated)

Latest DXR, INVO, SINT, MOTS, and RDGL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
3/27/2024	Q4 2023	SINT Sintx Technologies	N/A	-$0.09	-$0.09	-$0.09	N/A	$0.90 million
3/18/2024	Q4 2023	MOTS Motus GI	N/A	-$4.13	-$4.13	-$3.78	N/A	$0.06 million
3/18/2024	Q4 2023	RDGL Vivos	N/A	-$0.01	-$0.01	-$0.01	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DXR Daxor	$0.03	0.31%	N/A	N/A	N/A
INVO INVO Bioscience	N/A	N/A	N/A	N/A	N/A
MOTS Motus GI	N/A	N/A	N/A	N/A	N/A
RDGL Vivos	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DXR Daxor	N/A	N/A	N/A
INVO INVO Bioscience	2.94	0.15	0.12
MOTS Motus GI	0.46	1.76	1.69
RDGL Vivos	N/A	6.57	6.57
SINT Sintx Technologies	N/A	1.90	1.60

Ownership

Institutional Ownership

Company	Institutional Ownership
DXR Daxor	1.34%
INVO INVO Bioscience	12.02%
MOTS Motus GI	20.06%
RDGL Vivos	N/A
SINT Sintx Technologies	18.38%

Insider Ownership

Company	Insider Ownership
DXR Daxor	60.60%
INVO INVO Bioscience	3.50%
MOTS Motus GI	1.57%
RDGL Vivos	18.50%
SINT Sintx Technologies	1.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DXR Daxor	N/A	4.74 million	1.87 million	Not Optionable
INVO INVO Bioscience	25	2.74 million	2.65 million	No Data
MOTS Motus GI	15	5.03 million	4.95 million	Not Optionable
RDGL Vivos	1	388.87 million	316.93 million	Not Optionable
SINT Sintx Technologies	43	22.68 million	22.50 million	Not Optionable

DXR, INVO, SINT, MOTS, and RDGL Headlines

Source	Headline
	Prodways & SINTX announce deep technical ceramic 3D printing partnership tctmagazine.com - April 30 at 5:39 AM
	Why SINTX Technologies Shares Are Skyrocketing msn.com - April 29 at 1:54 PM
	SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT globenewswire.com - April 29 at 9:14 AM
	Why SINTX Technologies Stock Is Getting Hammered msn.com - April 3 at 2:48 PM
	SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock globenewswire.com - April 3 at 9:00 AM
	Why SINTX Technologies Stock Hit A New All-Time Low Today msn.com - April 1 at 3:51 PM
	DDC Appoints Vice President to Drive Operational Excellence itnewsonline.com - March 30 at 6:23 PM
	SINTX Technologies Announces Proposed Public Offering of Common Stock globenewswire.com - March 29 at 4:00 PM
	SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023 investorplace.com - March 28 at 7:02 AM
	Sintx Technologies Prices Public Offering Of $1.3 Mln Of Shares markets.businessinsider.com - March 25 at 1:22 PM
	Why SINTX Technologies Stock Is Down 50% msn.com - March 25 at 1:22 PM
	Why Is Sintx Technologies (SINT) Stock Down 31% Today? investorplace.com - March 25 at 9:05 AM
	SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock globenewswire.com - March 25 at 9:00 AM
	US Stocks Edge Lower; FedEx Posts Upbeat Earnings msn.com - March 23 at 3:15 AM
	Why SINTX Technologies Is Trading Higher Today aol.com - March 22 at 10:14 PM
	Gold Moves Lower; Lululemon Shares Plummet msn.com - March 22 at 5:14 PM
	Dow Dips 200 Points; Nike Shares Fall After Q3 Results markets.businessinsider.com - March 22 at 5:14 PM
	SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34% markets.businessinsider.com - March 22 at 5:14 PM
	Why SINTX Technologies Stock Is Nosediving msn.com - March 22 at 5:14 PM
	SINTX Technologies Announces Proposed Public Offering of Common Stock globenewswire.com - March 22 at 8:30 AM
	Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20 msn.com - February 24 at 2:14 PM
	Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI) benzinga.com - February 23 at 7:50 AM
	SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET finance.yahoo.com - February 21 at 3:58 PM
	SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET globenewswire.com - February 21 at 9:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Daxor

NASDAQ:DXR

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

INVO Bioscience

NASDAQ:INVO

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Motus GI

NASDAQ:MOTS

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Vivos

OTCMKTS:RDGL

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Sintx Technologies

NASDAQ:SINT

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial